Oral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients With Blood Cancers
Author(s) -
Stacie B. Dusetzina,
Haiden A. Huskamp,
Shelley A. Jazowski,
Aaron N. Winn,
William A. Wood,
Adam J. Olszewski,
Ethan Basch,
Nancy L. Keating
Publication year - 2019
Publication title -
jnci journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djz243
Subject(s) - medicine , discontinuation , parity (physics) , observational study , multiple myeloma , particle physics , physics
In this study, we sought to estimate the association between oral oncology parity law adoption and anticancer medication use for patients with chronic myeloid leukemia or multiple myeloma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom